Mumbai|HL
Vivek Vasudev Kamath will assume role of Managing Director Designate from December 16, 2016 as K. G. Ananthakrishnan (KG) current Managing Director of MSD in India will retire in the beginning of 2017
MSD in India operates its business in India through three legal entities, MSD Pharmaceuticals Private Limited, Organon (India) Private Limited, and Fulford (India) Limited.
Vivek joined MSD in India in July 2012 and is currently the Business Unit Director for Cardiovascular Metabolics and Market Access. KG and Vivek will work together to ensure smooth transition of business responsibilities.
Vivek Vasudev Kamath has over twenty five years of experience across India, South Asia & ASEAN markets. He brings rich experience with leading Indian and Multinational healthcare organizations in marketing, sales and general management. He has managed portfolios in prescription, over-the counter (OTC) & Diagnostics segments, partnering with healthcare professionals, consumers, diverse trade channels & Government/ non-Government healthcare entities.
Inputs: Agencies
